Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

123
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
123
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

534
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
534
Cancer Survival Analysis01:21

Cancer Survival Analysis

343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective serology reveals chikungunya exposure among hospitalized dengue suspected cases in Minas Gerais, Brazil, 2024.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026
Same author

SARS-CoV-2 drives upregulation of EpCAM in respiratory epithelial cells with hypercellular profile during severe COVID-19.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Label-Free Nanostructured Biosensing Platform Based on Depolarized Dynamic Light Scattering for Rapid and Portable Detection of Immunoglobulins in Complex Biological Samples.

ACS omega·2026
Same author

Antiviral Mechanisms of Justicidin B and Tuberculatin from <i>Phyllanthus brasiliensis</i> against Oropouche Virus Infection.

ACS omega·2026
Same author

Distinct CD8<sup>+</sup> T cell types associated with COVID-19 severity in unvaccinated HLA-A2<sup>+</sup> patients.

iScience·2026
Same author

Immune landscape of COVID-19 recovery: Nucleocapsid as a major target of CD8+ T cell antiviral responses in convalescent HLA-A*02+ individuals from Brazil.

Journal of leukocyte biology·2026

Related Experiment Video

Updated: Jun 25, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

Algorithms for predicting COVID outcome using ready-to-use laboratorial and clinical data.

Alice Aparecida Lourenço1, Paulo Henrique Ribeiro Amaral2, Adriana Alves Oliveira Paim1

  • 1Laboratório de Virologia Básica e Aplicada, Instituto de Ciências Biológicas, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Frontiers in Public Health
|May 29, 2024
PubMed
Summary

Machine learning models using hematological and biochemical data can predict COVID-19 patient outcomes. Urea levels, particularly at early time points, are key indicators of disease severity and mortality risk.

Keywords:
COVID-19SARS-CoV-2hematological and biochemical parametersmachine learningpredictive biomarkers

More Related Videos

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.5K
Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K

Related Experiment Videos

Last Updated: Jun 25, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.5K
Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K

Area of Science:

  • Biomedical Informatics
  • Clinical Pathology
  • Machine Learning in Healthcare

Background:

  • The COVID-19 pandemic highlighted the need for tools to predict patient outcomes.
  • Existing methods for predicting COVID-19 severity are limited in combining hematological and biochemical data.
  • Early identification of severe cases is crucial for effective public health management.

Purpose of the Study:

  • To develop and validate machine learning algorithms for predicting COVID-19 mortality or survival.
  • To identify key hematological and biochemical parameters that serve as biomarkers for COVID-19 severity.
  • To assess the utility of dynamic monitoring of these parameters for outcome prediction.

Main Methods:

  • Utilized RT-PCR confirmed SARS-CoV-2 patient data.
  • Collected hematological and biochemical measurements at three distinct hospital admission time points.
  • Developed and applied machine learning algorithms to predict patient outcomes (mortality/survival).

Main Results:

  • Urea was identified as the most significant predictor of patient severity and outcome across all time points.
  • Early time point (T1) analysis highlighted urea, lymphocytes, glucose, basophils, and age as important features.
  • The predictive power of other parameters varied dynamically across the three time points.

Conclusions:

  • Machine learning models integrating hematological and biochemical data offer a powerful tool for predicting COVID-19 patient outcomes.
  • Urea is a critical biomarker for assessing COVID-19 severity and predicting mortality.
  • A dynamic, time-dependent approach to parameter monitoring is essential for accurate patient outcome prediction.